Skip to content
10-Q

Quarterly Report

Nabriva Therapeutics plc

0001558370-23-016524

← back to feed
Filed
Oct 19, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Sep 11, 2023 3.23M sh
Shares Diluted Q2 2023 · Jun 30, 2023 3.23M sh
Shares Diluted Q2 2023 · Jun 30, 2023 3.23M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 2.53M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 2.44M sh
Capex Q2 2023 · Jun 30, 2023 $3K
Capex Q2 2023 · Jun 30, 2022 $99K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$5.11M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$28.91M
Long Term Debt Q2 2023 · Jun 30, 2023 $344K
Long Term Debt Q2 2023 · Dec 31, 2022 $388K
Short Term Debt Q2 2023 · Jun 30, 2023 $196K
Short Term Debt Q2 2023 · Dec 31, 2022 $4.83M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $2.18M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $12.41M
Stockholders Equity Q2 2023 · Jun 30, 2023 −$16.32M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$4.36M
Stockholders Equity Q2 2023 · Dec 31, 2022 $3.29M
Stockholders Equity Q2 2023 · Jun 30, 2022 $34.61M
Stockholders Equity Q2 2023 · Mar 31, 2022 $44.63M
Stockholders Equity Q2 2023 · Dec 31, 2021 $53.35M
Current Liabilities Q2 2023 · Jun 30, 2023 $26.2M
Current Liabilities Q2 2023 · Dec 31, 2022 $27.61M
Total Liabilities Q2 2023 · Jun 30, 2023 $26.9M
Total Liabilities Q2 2023 · Dec 31, 2022 $28.47M
Current Assets Q2 2023 · Jun 30, 2023 $9.95M
Current Assets Q2 2023 · Dec 31, 2022 $31.1M
Total Assets Q2 2023 · Jun 30, 2023 $10.58M
Total Assets Q2 2023 · Dec 31, 2022 $31.77M
Eps Diluted Q2 2023 · Jun 30, 2023 −$3.73
Eps Diluted Q2 2023 · Jun 30, 2023 −$6.43
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$4.38
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$9.38
Eps Basic Q2 2023 · Jun 30, 2023 −$3.73
Eps Basic Q2 2023 · Jun 30, 2023 −$6.43
Eps Basic restated Q2 2023 · Jun 30, 2022 −$4.38
Eps Basic restated Q2 2023 · Jun 30, 2022 −$9.38
Sga Expense Q2 2023 · Jun 30, 2023 $4.11M
Sga Expense Q2 2023 · Jun 30, 2023 $13.11M
Sga Expense Q2 2023 · Jun 30, 2022 $11.05M
Sga Expense Q2 2023 · Jun 30, 2022 $23.75M
Rd Expense Q2 2023 · Jun 30, 2023 $1.09M
Rd Expense Q2 2023 · Jun 30, 2023 $3.71M
Rd Expense Q2 2023 · Jun 30, 2022 $4.09M
Rd Expense Q2 2023 · Jun 30, 2022 $7.61M
Net Income Q2 2023 · Jun 30, 2023 −$12.06M
Net Income Q2 2023 · Jun 30, 2023 −$20.76M
Net Income Q2 2023 · Mar 31, 2023 −$8.7M
Net Income Q2 2023 · Jun 30, 2022 −$11.07M
Net Income Q2 2023 · Jun 30, 2022 −$22.89M
Net Income Q2 2023 · Mar 31, 2022 −$11.82M
Operating Income Q2 2023 · Jun 30, 2023 −$12.02M
Operating Income Q2 2023 · Jun 30, 2023 −$20.5M
Operating Income Q2 2023 · Jun 30, 2022 −$10.4M
Operating Income Q2 2023 · Jun 30, 2022 −$21.96M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $9.07M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $13.51M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $4.46M
Cost Of Revenue Q2 2023 · Jun 30, 2022 $7.82M
Revenue Q2 2023 · Jun 30, 2023 $2.24M
Revenue Q2 2023 · Jun 30, 2023 $9.83M
Revenue Q2 2023 · Jun 30, 2022 $9.19M
Revenue Q2 2023 · Jun 30, 2022 $17.21M